Wingstop has bought back more than 2.5 million of its own shares since the summer of 2023, to the tune of nearly $700 million ...

Shares of Oddity Tech climbed after the company's board of directors authorized a $200 million share-repurchase program. The stock jumped 7% to $13.41 in Thursday afternoon trading. The shares have ...

The firm raised funds in November at $40 billion from major investors, indicating a 25% higher valuation despite tumbling bitcoin and XRP prices.

Prenetics Global (PRE) traded higher on Friday after the supplement maker announced plans to repurchase shares worth up to $40M over 12 months. The Hong Kong-based company said that its board ...

Constellium SE (NYSE: CSTM) announced today that the Board of Directors has authorized a new share repurchase program of up to $300 million of the Company's outstanding ordinary shares, which will ...

LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a ...

AtkinsRealis Group intends to renew its share-repurchase program to buy back about 10% of its common shares over the course of a one-year period. The Montreal-based engineering- and ...

The Dallas-based fast-casual chain’s board of directors announced a significant expansion of its share repurchase program ...

SINGAPORE, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) ("Antalpha" or the "Company") today announced that its board of directors has authorized a share ...

Stellus Capital Investment Corporation (SCM) Q4 2025 Management View CEO Robert Ladd opened the call by highlighting the company's financial results and a series of strategic updates, including the ...

Virtus Dividend, Interest & Premium Strategy Fund (NYSE: NFJ) (the "Fund"), a closed-end fund, announced today that the Board of Trustees approved the renewal of its open market share repurchase ...

BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...